Medicare will negotiate the price of Botox and 14 other drugs this year
Inflatie
The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations. The list includes Botox and the GLP-1 drug Trulicity. The negotiations stem from President Joe Biden’s Inflation Reduction Act of 2022 , which gave the Centers for Medicare and Medicaid Services the authority to haggle over prices on the costliest prescription drugs each year. The results from the first round of negotiated prices went into effect this year . The drugs selected
din zilele anterioare